Barclays Downgrades Adient to Equal-Weight, Lowers Price Target to $37
Portfolio Pulse from Benzinga Newsdesk
Barclays analyst Dan Levy downgraded Adient (NYSE:ADNT) from Overweight to Equal-Weight and reduced the price target from $41 to $37.
April 10, 2024 | 2:53 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Adient's stock rating was downgraded by Barclays from Overweight to Equal-Weight, and its price target was lowered from $41 to $37.
The downgrade by a major financial institution like Barclays, coupled with a reduction in the price target, typically signals a less optimistic outlook on the stock's future performance. This can lead to a negative perception among investors, potentially causing a short-term decrease in the stock price.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100